88IV - PR Newswire Asia's news


GV Announces Cooperation with Top 500 Company in China TORONTO , May 17, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the ... 2024-05-17T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
LiveSpo Pharma Emerges as Vietnam's Pioneer at Vitafoods Europe 2024, Unveiling Groundbreaking Research and Product Development to Reduce Antibiotic Use in Digestive and Respiratory Care HANOI, Vietnam , May 17, 2024 /PRNewswire/ -- LiveSpo Pharma is the first Vietnamese entity to report on clinical studies at Vitafoods Europe 2024, held in Geneva, Switzerland . LiveSpo Pharma ... 2024-05-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference Data presentations including the extended LIBERTY studies to highlight the long-term treatment goals of ZYMFENTRA ™ , the first and only FDA-approved subcutaneous infliximab The data ... 2024-05-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality Australian animal health leader adopts Veeva Vault QualityDocs and Veeva Vault Training for greater efficiency and compliance ... 2024-05-17T Banking/Financial Service Biotechnology Health Care/Hospital Internet Technology
Seegene and Springer Nature Announce Strategic Alliance - Strategic alliance aims to foster collaboration with researchers working in various disease fields by using best-in-class PCR diagnostic technology ... 2024-05-16T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Visionary Has World-Class Biochip Technology Products TORONTO , May 16, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science ... 2024-05-16T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
HSA approves GSK's Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults [1] Arexvy has been approved by the Health Sciences Authority (HSA) of Singapore for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus ... 2024-05-16T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
EHA 2024 \| Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress SUZHOU, China and ROCKVILLE, Md. , May 16, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis ... 2024-05-16T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ractigen Therapeutics Receives IND Approval from China's NMPA to Initiate Phase 1 Clinical Trials for RAG-17 in SOD1-ALS Patients SUZHOU, China , May 15, 2024 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage pharmaceutical company committed to developing pioneering therapies, today announces that the Center for ... 2024-05-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Everest Medicines Announces Commercial Launch and First Prescription for NEFECON® in Mainland China SHANGHAI , May 14, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ... 2024-05-14T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology